Navigation Links
Ground Zero Pharmaceuticals, Inc. (GZP) Announces Expansion of Oncology Programs for Its Clients
Date:10/27/2011

affairs, product development, and clinical consulting firm providing strategic and tactical services to the pharmaceutical, biotechnology and medical device industries.  These include regulatory representation and submissions, medical consulting and monitoring, preclinical planning, auditing of clinical, nonclinical and manufacturing sites, medical writing, chemistry, manufacturing and controls consulting, clinical trial execution, data management, biostatistics, and project management.  GZP has resources throughout the US, Canada, Australia and Europe, and a wholly owned subsidiary in Brisbane and Melbourne, Australia.

For further information please contact Ms. Tisha Templeton, Senior Vice President, Finance and Operations, Ground Zero Pharmaceuticals, Inc., +1-949-419-6136, fax, +1-949-861-9797, ttempleton@groundzerous.com.

Web Site: http://www.groundzerous.com


'/>"/>
SOURCE Ground Zero Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pharmaceutical Industry Leaders to Tackle Groundbreaking Challenges, Opportunities for Pharma & Biotech at Elite Event
2. Rottenstein Law Group Heeds Groundswell of Grievances Against Manufacturers of Defective, Dangerous Hip Replacement Devices
3. Femasys and Norgenix Announce Distribution Agreement for Groundbreaking New Device for Infertility Diagnosis
4. Groundbreaking Report Details the New $80 Billion Accountable-Care Market
5. International Dyslexia Association Announces Groundbreaking Parent Membership Initiative in Response to 40,000 Annual Inquiries
6. Newborn Possibilities Fund Awards Grant to Georgia Health Sciences University Foundation to Support Groundbreaking Pediatric Research
7. Glenveigh Medical and Monica Healthcare Announce Distribution Agreement for Groundbreaking FDA Cleared Wireless Fetal Monitoring System
8. SinoFresh Healthcare, Inc. Takes Groundbreaking Products to Europe
9. Emerging Markets Are Gaining Ground in Medical Technology Innovation; U.S. Maintains Lead, Finds PwCs Medical Technology Innovation Scorecard
10. Groundbreaking Study Showed Bayers Advantage Multi® for Dogs (imidacloprid + moxidectin) Topical Solution was the only Heartworm Preventive Tested That Demonstrated 100 Percent Efficacy against the Challenging MP3 Strain
11. Pharma Industry Leaders to Reveal Hottest, Latest Trends for Pharma & Biotech at Groundbreaking Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 28, 2015 On the afternoon of August ... of CPI International, Inc. (CPI), plans to file its ... 2015 with the Securities and Exchange Commission and to ... quarter.  At 11 a.m. (EDT) on Wednesday, August 12, ... conjunction with this release that will be Web cast ...
(Date:7/28/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cng4gn/refurbished ) has ... Market - Global Forecasts to 2019" report to ... market is estimated to grow expected to reach $9.37 ... 2014 to 2019. Factors such ... financial constraints, increasing privatization in the healthcare sector, and ...
(Date:7/28/2015)... 28, 2015 A German Diabetes Center clinical ... reuteri probiotic enriches human gut microbiota and modifies ... The study involved daily administration of Nutraceutix,s L. ... the patented BIO- tract ® delivery technology ... on their way to the intestinal tract. ...
Breaking Medicine Technology:CPI International To Announce Third Quarter 2015 Financial Results 2Refurbished Medical Equipment Market 2015 - Global Forecasts to 2019 2Nutraceutix's L. reuteri Probiotic Clinically Proven to Modulate Gut Insulin Metabolism 2
... Sigma-Tau Pharmaceuticals, Inc. is pleased to announce ... Food and Drug Administration (FDA) to manufacture L-asparaginase, ... (pegaspargase).  ONCASPAR is the only FDA-approved PEGylated formulation ... the treatment of acute lymphoblastic leukemia (ALL). The ...
... ATLANTA and IRVINE, Calif., April 18, 2011 CryoLife, ... medical device and cardiovascular tissue processing company, today announced ... part of its definitive agreement with Cardiogenesis Corporation ("Cardiogenesis"), ... 49.9 percent of the outstanding shares of Cardiogenesis. ...
Cached Medicine Technology:Sigma-Tau Pharmaceuticals Announces Approval for New Manufacturing Process for ONCASPAR® (Pegaspargase) Primary Ingredient 2Sigma-Tau Pharmaceuticals Announces Approval for New Manufacturing Process for ONCASPAR® (Pegaspargase) Primary Ingredient 3Sigma-Tau Pharmaceuticals Announces Approval for New Manufacturing Process for ONCASPAR® (Pegaspargase) Primary Ingredient 4CryoLife Announces Expiration of Go-Shop Period Related to its Proposed Acquisition of Cardiogenesis Corporation 2CryoLife Announces Expiration of Go-Shop Period Related to its Proposed Acquisition of Cardiogenesis Corporation 3CryoLife Announces Expiration of Go-Shop Period Related to its Proposed Acquisition of Cardiogenesis Corporation 4CryoLife Announces Expiration of Go-Shop Period Related to its Proposed Acquisition of Cardiogenesis Corporation 5CryoLife Announces Expiration of Go-Shop Period Related to its Proposed Acquisition of Cardiogenesis Corporation 6CryoLife Announces Expiration of Go-Shop Period Related to its Proposed Acquisition of Cardiogenesis Corporation 7
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... Wedding season is in full swing, which ... the extra pressure of looking good on the big day. Every bride wants to look ... a new level. , According to a recent study by the ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... Farmer, airing fall of 2015 on RFD-TV. , Fastline is dedicated to quality ... about Fastline.com, which contains the largest and freshest searchable agriculture equipment database in ...
(Date:7/29/2015)... ... July 29, 2015 , ... A June 10, 2015 ... Skin Cancer ," discussed the importance of having regular skin cancer screenings from an ... excessive exposure to ultraviolet rays. When caught early, skin cancer is rarely fatal; however, ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... patients in a Clinical Performance Study for the Invisiport at Wheaton Franciscan Healthcare ... French catheter options, offers a less invasive, patient-friendly alternative to traditional chest ports ...
(Date:7/29/2015)... ... 2015 , ... Attorneys representing American families in national talcum powder lawsuits announce ... features a page dedicated to news related to pending talcum powder lawsuits, as well ... Lawsuit News page was launched with eight initial articles. , “We decided to ...
Breaking Medicine News(10 mins):Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 2Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 3Health News:Fastline Publications to Partner with American Farmer in Upcoming Episode Airing on RFD-TV 2Health News:Get Checked for Skin Cancer Early and Often 2Health News:Get Checked for Skin Cancer Early and Often 3Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 2Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 3Health News:National Attorneys Provide Regular Talcum Powder Lawsuit News Updates 2Health News:National Attorneys Provide Regular Talcum Powder Lawsuit News Updates 3
... ) will hold a conference call to discuss its fourth,quarter and full ... Fourth quarter and full year 2007 results will be,released to the public ... Call-in number for U.S. participants: ... international participants: (617) 213 - 4868 Participant access code: ...
... options for ... WAUKESHA, Wis., Feb. 8 LifeCare Hospitals of Wisconsin,is ... Advanced Wound,Healing. The hospital will hold an open house for ... Wednesday, February 13,from 4:00 p.m. to 6:00 p.m., The ...
... http://www.nhs.uk ), the,online ,front door, to the NHS, ... make sense of the stories appearing in the ... NHS Choices,( http://www.nhs.uk/News/Pages/NewsIndex.aspx ), is an evidence-based,analysis of ... explains the,facts behind newspaper headlines and an understanding ...
... gastrointestinal illness risk, study says , , FRIDAY, Feb. 8 (HealthDay ... to stay on dry sand as much as possible, suggests ... of three Florida beaches to assess possible health effects of ... no increased health risk due to exposure to sand on ...
... percent of liver cancer is caused by stem cells gone ... all growth control. But, despite years spent looking, no one ... even normal stem cells in the organ. Until now. , ... the National Academy of Sciences (PNAS), researchers at Georgetown University ...
... Shows Independents Holding Fast on Health ... Feb. 8 Concern about health care,continues to hold ... somewhat for Democrats and Republicans since last fall, according ... by the American,College of Surgeons (ACS)., The vast ...
Cached Medicine News:Health News:Huntsman to Discuss Fourth Quarter and Full Year 2007 Results on Friday, February 22, 2008 2Health News:LifeCare Hospitals of Wisconsin Unveils Center for Advanced Wound Healing 2Health News:Staying Dry at Beach May Spare Your Stomach 2Health News:Discovery of good -- and bad -- liver stem cells raises possibility of new treatment 2Health News:Discovery of good -- and bad -- liver stem cells raises possibility of new treatment 3Health News:Independent Voters Remain Worried about Health Care 2Health News:Independent Voters Remain Worried about Health Care 3
Used for access and catheterization procedures. Double flexible tipped design permits alternative use of both ends of wire guide depending upon procedural needs. Supplied sterile in peel-open package...
... Merit Medical is pleased to offer ... The pre-coated, high-performance, InQwire guide wire ... is very lubricious and can help ... available in a wide range of ...
... The MULTI-LINK VISION Coronary Stent System ... of cobalt chromium stents. Cobalt chromium is ... so a cobalt chromium stent can have ... stainless steel stent with struts that are ...
BiodivYsio stent with biocompatible coating (phosphorylcholine)...
Medicine Products: